Tagged with ARM

Pharma Legal Handbook The key facts about regulatory reforms in Belgium. Prepared in association with ALTIUS, a leading law firm in Belgium, this is an extract from The Pharma Legal Handbook: Belgium, available to purchase here for USD 99.   1. Are there proposals for reform or significant change to the healthcare system? As of recently,…

Pharma Legal Handbook Keen to learn more about patents & trademarks in Belgium? Read on! Prepared in association with ALTIUS, a leading law firm in Belgium, this is an extract from The Pharma Legal Handbook: Belgium, available to purchase here for USD 99.   1. What are the basic requirements to obtain patent and trademark protection?…

Report PharmaBoardroom had the opportunity to sit down with over six hundred key stakeholders in the life sciences industry across fifteen different countries in 2019. The culmination of time spent in these countries and the insights gained from the interviews we conducted resulted in the publishing of thirteen country reports. Here…

Top 5 In 2019 PharmaBoardroom had the exclusive opportunity to speak with executives that are heading up some of European pharma’s top companies. These stakeholders provided insights into their visions and strategies for success and how they are embracing innovation as they forge ahead.      David Loew, Executive Vice President, Sanofi…

Hungary Péter Ferdinandy and Zsuzsanna Helyes, President and Secretary General of the Hungarian Society for Experimental and Clinical Pharmacology (HUPHAR), share their insights about the role of the society, the R&D capabilities of the Hungarian pharmaceutical industry, the ability of local players to bring innovations to the market, and the future…

Czech Republic Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted to her new position in a foreign country and turned the affiliate around by overhauling compliance processes and successful launches…

Hungary József Béres, President of Béres and Ferenc Major, CEO, share their insights on the history of the company, its performance and approach to creating brand awareness, the importance of R&D in their internationalization strategy, and the long-term vision of the company.   Healthcare elements are increasingly expensive, and the burden…

CEE With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the company’s success in the Central Eastern European region. Corina Croitoru, Managing Director for the Czech Republic and Slovakia, evaluates the challenges that come with bringing to market medicines on…

Czech Republic Josef Kredba, country manager Czech Republic at G.L. Pharma, an Austrian pharmaceutical company, explains how the company has returned to growth in the challenging Czech generics market and shares his thoughts on market access and pricing conditions for both innovative and generic products.   On the one hand, authorities recognize…

China The pharma industry tends to see a lot of personnel movement, particularly at management levels, but since the Chinese market started heating up a few years ago, the labour market has been left playing catch-up. As the Chinese government looks to streamline its regulatory approval processes, MNCs plan to expand…

Czech Republic Czech Republic’s overall pharma market value increased 5 per cent in 2019, while its units produced decreased by 1 per cent.   Made with Visme Presentation Maker   The number of clinical trials conducted in the Czech Republic increased in 2017 and fell to a three-year low in 2018. Made…

Czech Republic These are the 20 pharma companies in the Czech Republic, ranked by sales for the period between October 2018 and October 2019. Novartis came out on top with annual sales of USD 251.4 million, followed by Sanofi with USD 170.9 million and Roche with USD 149.8 million. Made with Visme…